#neuroendocrine carcinoma

[fleshwizard]

science doodles done at the lab during reunions

tertiary lymphoid structures

flow cytometry

leucocytes (back of the sketchbook)

neuroendocrine carcinoma

psoriasis

cellular leiomyoma

[hybridmindthoughtsreloaded]

Turbo Cancers

One interesting story that seems to be buried is all the young social media influencers from YouTube, Instagram, and TikTok that took the jab are getting turbo cancers.

July 9, 2023 – Sam and Colby (10 million subscribers) – 26 year old Colby Brock was diagnosed with testicular cancer. https://youtu.be/gn6nAkg9Ltw

July 3, 2023 – 37 year old Grace Helbig (2.6 million subscribers) Reveals She’s Battling Breast Cancer at 37 – she was diagnosed with Stage 2A Triple-Positive Breast cancer. https://youtu.be/QG2nTvma-ZE

Aug. 10, 2023 – Mexican TikTok Star, 25 year old Emilio Betancourt (3.2 million TikTok followers) announced he had cancer recurrence (Osteosarcoma) with no treatment options. https://youtu.be/YolbM7LheDA

May 26, 2023 – Buenos Aires, Argentina – 33 year old Aylen Milla (1 million Instagram followers) was diagnosed with very aggressive breast cancer. https://youtu.be/zo6QEq6ZJyk

May 19, 2023 – vlogbrothers (3.74 million subscribers) – with John Green and Hank Green. 43 year old Hank was diagnosed with Hodgkin Lymphoma. He promoted COVID-19 vaccines in 2021. https://youtu.be/x6a4hMyiwBo

May 16, 2023 – Mermaid Zelda (152k subscribers) was diagnosed with lymphoma. https://youtu.be/qfFlpwYjYmg

May 2023 – TikTok star Anthony Carrodo (500K TikTok followers) was diagnosed with lymphoma (DLBCL).

April 22, 2023 – Karina Reske (30.5k subscribers) was diagnosed with breast cancer recurrence and metastasis. She was in remission for 5 years. https://youtu.be/5bmJNuqHMHY

April 21, 2023 – Lizzy Musi Racing (66.2K subscribers) – was diagnosed with Stage 4 breast cancer. https://youtu.be/_iLcwRIwXyk

April 12, 2023 – Jessica Brock (63.7k subscribers) was diagnosed with three ovarian tumors up to 16cm, one was a malignant teratoma. https://youtu.be/4DYB4YWVU_4

March 4, 2023 – 21 year old Kyedae Shymko (1.1 million Instagram followers, 2.2 million Twitch followers), was diagnosed with Leukemia (AML). https://youtu.be/eUT9w8u2FUA

Feb. 4, 2023 – 39 year old Chad Wild Clay (14.7 million Youtube subscribers, 1 million Instagram followers) – was diagnosed with extremely rare myxopapillary ependymoma (spinal cancer). https://youtu.be/9FNXk3UDVxQ

Jan. 26, 2023 – Tiktok Influencer “Enkyboys” Randy Gonzalez (15.7 million TikTok followers, 2 million Instagram followers) announced in April 2022 he was diagnosed with Stage 4 Colon cancer. He was given 3 to 5 years to live by his doctors, he died 8 months later. https://youtu.be/mr7FGUy8h-0

Nov. 22, 2022 – 24 year old Andrea Barba (11.9k subscribers) – was diagnosed with Gastric Cancer (Stage 1B). https://youtu.be/j9r7ORs1k0E

Jul. 2022 – 33 year old Jenny Appleford (114k subscribers) was diagnosed with Stage 3 Lung cancer in March 2021 that has progressed rapidly to Stage 4 metastatic to brain. https://youtu.be/dHIhnM9T_gc

Jun. 30, 2022 – 23 year old Minecraft Youtuber Technoblade (16.5 million subscribers) died of metastatic sarcoma after being diagnosed in Aug. 2021. https://youtu.be/g9_aYyEDMD0

Jun. 19, 2022 – 36 year old Jessica Krock (Krocks in the Kitchen, 103k subscribers) – was diagnosed with Stage 3 Neuroendocrine carcinoma of the left ovary.

May 25, 2022 – Austin, TX – 39 year old Nasreen Shahi is a popular fashion blogger (477k Instagram followers) who was diagnosed with breast cancer late in 2021.

Apr. 21, 2022 – Tess Christine (2.3 million subscribers) was diagnosed with breast cancer in March 2022.

Jan. 23, 2022 – Eamon & Bec (1.23 million subscribers) – was diagnosed with stage 3 breast cancer in Dec. 2021.

Nov. 2021 – Stephanie Williams, Registered Nurse and TikToker (19K followers) was diagnosed with Stage 3 Lung cancer.

[grapenehifics]

Chapter 55

(Link: https://archiveofourown.org/works/40473339/chapters/110929722)

This chapter was a difficult one to hit 'post' on because - well, because of the subject matter, A - but also B, because I've known this was going to happen all along and have been dancing around it for ages trying not to give too much away, and usually the anticipation of that is fun - but it's not so fun when it's a really sad, negative thing I have to share!

And then of course, because of how the chapter breaks shook out, I'm left feeling like I buried the lede of this chapter, so to speak, way down at the end. Other things happen, too, that aren't Satine being diagnosed with cancer, but they're understandably very overshadowed by Satine's diagnosis.

But! In the midst of all that, Ahsoka quits swim team, Anakin and Padme find out they're having twins (that's really not so much of a surprise, though, is it? Only to the characters, not to us), Obi-Wan is still trying to bury his feelings, Ahsoka starts high school and makes friends with Barriss, and Anakin tries very hard to be a good dad.

Partly out of respect to the fact that I have no practical knowledge of neuroendocrine cervical carcinomas, malignant or otherwise, and partly just because it makes me sad and I didn't want to do it, this fic is pretty light on the actual medical stuff. (Where I'm better is with the dealing with the medical emergencies type stuff - insurance and FMLA and how much goddamn time you spend on the phone even when you have (or thought you had) quote-unquote 'good' insurance. So we'll hit those bits a little harder. Write what you know, and all that.)

It was also really, really important to me to show Satine's family, biological, by marriage, by choice, and otherwise - circling the wagons around her, and how each of them contributes. So it was time to bring back Bo-Katan, and Korkie, and Luminara (and Barriss), and Aayla, and have Anakin and Ahsoka and Obi-Wan all work out what their role in her care is, even though none of them have any medical training. Because none of this happens in a vacuum, and it's never just happening to the person who is actually sick.

[colinwilson11]

Merkel cell carcinoma (MCC) is a rare form of skin cancer originating from neuroendocrine Merkel cells and widely believed to have a viral etiology. MCC typically presents as a firm,red nodule on sun-exposed areas of skin. With risk factors including older age,immunosuppression and UV exposure,the incidence of MCC has been rising sharply over the last two decades. Treatment involves surgery combined with potential adjuvant radiation or systemic therapy.

[jdrsandeep]

Appendix Cancer: Understanding the Disease and Raising Awareness

Appendix cancer is a rare but serious form of cancer that affects the appendix, a small pouch attached to the large intestine. While often overlooked, appendix cancer deserves significant attention due to its complexity and impact on patients. At Abdominal Cancer Day, our mission is to raise awareness, promote research, and support those affected by various types of abdominal cancers, including appendix cancer.

What is Appendix Cancer?

Appendix cancer occurs when cells in the appendix begin to grow uncontrollably, forming a tumor. There are different types of appendix cancer, which vary in their level of aggressiveness. The two main categories include:

Neuroendocrine Tumors (Carcinoid Tumors): These are the most common type of appendix cancer. They often grow slowly and may not cause symptoms until they have progressed significantly.

Adenocarcinoma: This is a more aggressive type of appendix cancer. It resembles the cancer that forms in the colon and is usually detected when it has already spread to other parts of the body, such as the abdominal cavity.

Other less common forms of appendix cancer include goblet cell carcinoma and signet ring cell carcinoma, which tend to have poor prognoses.

Symptoms and Diagnosis

One of the challenges of appendix cancer is that it often presents without noticeable symptoms, or it mimics other abdominal conditions such as appendicitis. Symptoms may include abdominal pain, bloating, changes in bowel habits, and unintentional weight loss. In some cases, the cancer may only be detected during surgery for another condition, such as an appendectomy.

Because appendix cancer is rare and its symptoms are not specific, diagnosis can be delayed. Physicians typically use imaging techniques like CT scans or MRIs to detect abnormalities in the appendix. If cancer is suspected, a biopsy may be performed to confirm the diagnosis.

Treatment Options

Treatment for appendix cancer depends on several factors, including the type of tumor, its size, and whether it has spread to other areas of the body. Common treatment options include:

Surgery: Surgery is often the primary treatment for appendix cancer. Depending on the stage of the disease, it may involve removing the appendix (appendectomy), part of the colon (hemicolectomy), or other affected areas of the abdomen. In advanced cases, a procedure called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) may be performed. This is a highly specialized treatment aimed at removing as much of the cancer as possible and then treating the remaining cancer cells with heated chemotherapy.

Chemotherapy: Systemic chemotherapy may be recommended, particularly if the cancer has spread. This treatment involves using drugs to destroy cancer cells throughout the body.

Radiation Therapy: Although less commonly used, radiation therapy may be an option for certain cases, particularly when tumors cannot be completely removed through surgery.

Importance of Awareness and Support

At Abdominal Cancer Day, we are committed to raising awareness about appendix cancer and ensuring that patients and their families have access to the resources and support they need. Early detection is critical for improving outcomes, which is why it's important to be informed about the signs and risk factors associated with this rare disease.

Patients diagnosed with appendix cancer often face uncertainty, not only because of the rarity of the disease but also due to the lack of standardized treatment protocols. We work to bridge this gap by connecting patients with leading specialists and researchers in the field. Through educational campaigns, support networks, and fundraising efforts, Abdominal Cancer Day aims to shine a light on this often overlooked form of cancer and promote advancements in research and treatment.

Conclusion

Appendix cancer may be rare, but its impact on patients is profound. Raising awareness about this disease, supporting those affected, and promoting research are essential steps toward improving outcomes for patients.

 At Abdominal Cancer Day, we are dedicated to making a difference in the lives of those affected by abdominal cancers, including appendix cancer. By spreading knowledge, fostering community support, and advocating for research, we can help ensure that no one faces appendix cancer alone.

Read More Info : Laparoscopic Cancer Surgery

breast cancer awareness

[arvachin]

Pancreatic Cancer: Symptoms, Causes, Diagnosis, Treatment & More

Pancreatic cancer cases, although not very common, still persist in India. According to recent surveys, there are approximately 0.5–2.4 cases per 100,000 men and around 0.2–1.8 cases of pancreatic cancer for every 100,000 women. To effectively combat this issue, early detection is crucial. We’re here to guide you through understanding, recognizing, and managing this serious health concern. Read on to stay informed about its types, stages, symptoms, and prevention.

What is Pancreatic Cancer?

Types of Pancreatic Cancer

Pancreatic cancer can be classified into several types:

Adenocarcinoma: The most common type, developing in the cells that line the pancreatic duct. Early detection is difficult, and it tends to grow rapidly, making timely intervention crucial.

Neuroendocrine Tumors (NETs): Less common, these tumors can either produce hormones (functional) or not (non-functional). They typically grow slower than adenocarcinomas.

Cystic Lesions: Fluid-filled sacs in the pancreas, which are mostly harmless but some can turn cancerous. Regular check-ups are essential to monitor their development.

Acinar Cell Carcinoma: A rare type, starting in the cells responsible for producing digestive enzymes. Its behavior differs from the more common adenocarcinoma.

Stages of Pancreatic Cancer

Stage I: Cancer is confined to the pancreas. Surgery is often an option for effective removal.

Stage II: Cancer may reach nearby tissues but not major blood vessels. Treatment options like surgery are considered effective.

Stage III: Cancer has progressed to major blood vessels. A comprehensive approach with surgery, chemotherapy, and radiation may be recommended.

Stage IV: In this advanced stage, cancer has spread to distant organs. The focus shifts to improving the patient’s quality of life and managing symptoms.

Symptoms of Pancreatic Cancer

Digestive Issues: Changes in bowel habits, such as light-colored stools or dark urine.

Jaundice: Yellowing of the skin and eyes due to bile duct blockage.

Unintended Weight Loss: Losing weight without trying.

Abdominal Pain: Persistent pain in the abdomen or back.

Loss of Appetite: A decrease in the desire to eat.

New-Onset Diabetes: Development of diabetes without a clear explanation.

Fatigue: Feeling unusually tired or weak.

These symptoms, especially when persistent, should prompt consultation with a healthcare professional for further evaluation and diagnosis. Early detection is crucial for effective management.

Causes of Pancreatic Cancer

Smoking

Family History of pancreatic cancer

Chronic Pancreatitis: Long-term inflammation of the pancreas

Age: More common in older adults

Overweight or Obesity

Uncontrolled Diabetes

Dietary Factors: High in red and processed meats

Occupational Exposure: Chemicals and petroleum industries

Complications Associated with Pancreatic Cancer

As pancreatic cancer grows, it can cause complications such as:

Spread to Nearby Organs: Complicating treatment.

Blockage of the Digestive System: Affecting nutrient absorption.

Jaundice: Yellowing of skin due to bile duct blockage.

Blood Vessel Involvement: Posing additional challenges for treatment.

Diabetes Development: Leading to new-onset diabetes.

Pain and Discomfort: Persistent abdominal pain impacting quality of life.

Diagnostic Tests for Pancreatic Cancer

Imaging Tests: CT Scan, MRI, Ultrasound

Blood Tests: CA 19–9, Liver Function

Biopsy: Fine Needle Aspiration (FNA)

Endoscopic Tests: EUS, ERCP

Laparoscopy: Direct Visualization

These tests aid in diagnosing pancreatic cancer and guiding appropriate treatment approaches. If symptoms arise, prompt medical attention ensures timely intervention.

Prevention of Pancreatic Cancer

Prevention is better than cure. Follow these tips:

Quit Smoking

Maintain a Healthy Weight

Eat a Balanced Diet

Limit Alcohol Consumption

Stay Active

Manage Diabetes

Know Your Family History

Protect Against Occupational Risks

Consider Genetic Counseling in cases of a family history of pancreatic cancer

Treatment of Pancreatic Cancer

Diagnosis: Initial tests like CT scans and biopsies confirm the presence of pancreatic cancer.

Surgery: Depending on the stage, surgical procedures may remove the pancreatic cancer tumor, partially or entirely.

Chemotherapy: Powerful drugs eliminate cancer cells, administered before or after surgery.

Radiation Therapy: High-energy rays target and destroy cancer cells.

Targeted Therapy: Medications specifically target molecules involved in cancer growth.

Immunotherapy: Enhances the body’s immune system to combat cancer cells.

Palliative Care: Focuses on alleviating symptoms and improving the overall quality of life.

Clinical Trials: Participation in research studies exploring new treatments.

Conclusion

Recognizing symptoms, staying healthy, and seeking early treatment are key steps in effectively fighting pancreatic cancer. Personalized approaches like surgery and innovative treatments aim for better outcomes. Palliative care and keeping patients motivated are effective ways to enhance the quality of life. Making informed choices and staying proactive are vital in the fight against pancreatic cancer. For expert care and comprehensive treatment options, consider Arvachin Hospital, known for its dedication to patient well-being.

[drkamath]

Best Prostate Cancer Treatment in Bannerghatta Road Bangalore — Dr. Anil Kamath

When facing prostate cancer, finding the best treatment is crucial. For those in Bangalore, particularly on Bannerghatta Road, Dr. Anil Kamath is a top choice. In this article, we’ll explore why Dr. Kamath is a leading expert in prostate cancer treatment and what you can expect from the exceptional care available in this prominent location.

Understanding Prostate Cancer

What is Prostate Cancer?

Prostate cancer develops in the prostate, a small gland in men that produces seminal fluid. It’s one of the most common types of cancer in men. While some types of prostate cancer grow slowly and may need minimal treatment, others are aggressive and can spread quickly.

Types of Prostate Cancer

There are several types of prostate cancer, with the most common being adenocarcinoma. Other, less common types include small cell carcinoma, neuroendocrine tumors, and transitional cell carcinoma.

Why Choose Bannerghatta Road, Bangalore for Treatment

Medical Hub of Bangalore

Bannerghatta Road is renowned for its concentration of top-tier hospitals and medical institutions, making it a prime location for receiving advanced medical care.

Advanced Healthcare Facilities

The area boasts state-of-the-art healthcare facilities equipped with the latest technology and staffed by highly skilled medical professionals, ensuring the highest standard of care.

About Dr. Anil Kamath

Credentials and Experience

Dr. Anil Kamath is a highly esteemed oncologist with extensive experience in treating prostate cancer. His qualifications and dedication to patient care make him a top choice for those seeking the best treatment.

Contributions to Oncology

Dr. Kamath has made significant contributions to the field of oncology through his research and clinical practice. His work has been recognized with numerous awards and accolades.

Treatment Options for Prostate Cancer

Surgery

Surgery is a common treatment for prostate cancer, particularly when the cancer is confined to the prostate.

Types of Surgical Procedures

Radical Prostatectomy: Removal of the prostate gland and some surrounding tissue.

Laparoscopic Surgery: A minimally invasive surgery with quicker recovery times.

Robotic-Assisted Surgery: Offers precision and less recovery time.

Radiation Therapy

Radiation therapy uses high-energy rays to kill cancer cells.

Types and Techniques

External Beam Radiation Therapy (EBRT): Targets the prostate with radiation from outside the body.

Brachytherapy: Involves placing radioactive seeds inside the prostate.

Hormone Therapy

Hormone therapy helps to reduce the levels of male hormones that can fuel the growth of prostate cancer.

Purpose and Benefits

It’s often used when cancer has spread beyond the prostate or in combination with other treatments to enhance effectiveness.

Chemotherapy

Chemotherapy involves using drugs to kill rapidly growing cancer cells. It’s typically used for advanced prostate cancer or when other treatments haven’t been effective.

When It Is Used

It’s often considered when cancer has spread to other parts of the body and isn’t responding to hormone therapy.

Success Stories and Testimonials

Real-life Patient Stories

Hearing from patients who have successfully undergone treatment can be incredibly reassuring. Many patients treated by Dr. Kamath have shared their positive experiences and successful recoveries.

Testimonials from Survivors

Survivors’ testimonials highlight the expertise of Dr. Kamath and the compassionate care they received. These stories provide hope and encouragement to new patients.

Conclusion

Choosing the right treatment for prostate cancer is crucial, and Dr. Anil Kamath on Bannerghatta Road, Bangalore, offers some of the best care available. With advanced treatment options, a patient-centric approach, and a track record of success, Dr. Kamath provides hope and healing to those facing this challenging disease. If you or a loved one is battling prostate cancer, don’t hesitate to seek a consultation with Dr. Kamath. Your journey to recovery starts with the right choice.

[doctordiagnostics]

Men’s Prostate Cancer Health Checkup in Basavanagudi Bangalore — Dr Diagnostics

Prostate health is a critical aspect of men’s overall well-being, yet it often goes overlooked. Early detection of prostate cancer can make a significant difference in treatment outcomes and survival rates. In Basavanagudi, Bangalore, Dr Diagnostics provides comprehensive prostate cancer health checkups with cutting-edge technology and expert care.

Understanding Prostate Cancer

What is Prostate Cancer?

Prostate cancer develops in the prostate gland, a small walnut-shaped gland that produces seminal fluid. It’s one of the most common types of cancer in men.

Types of Prostate Cancer

There are several types of prostate cancer, with the most common being adenocarcinoma. Other types include small cell carcinoma, neuroendocrine tumors, and transitional cell carcinoma.

Risk Factors for Prostate Cancer

Risk factors include age (most cases are diagnosed in men over 50), family history, race (higher incidence in African-American men), and lifestyle factors such as diet and physical activity.

Prostate Cancer Screening Methods

PSA Test

How PSA Tests Work

The Prostate-Specific Antigen (PSA) test measures the level of PSA in the blood. Elevated PSA levels can indicate prostate cancer or other prostate conditions.

When to Get a PSA Test

Men should discuss with their doctor about starting PSA testing at age 50, or earlier if they have risk factors such as a family history of prostate cancer.

Digital Rectal Exam (DRE)

What to Expect During a DRE

During a DRE, a doctor inserts a gloved, lubricated finger into the rectum to feel for abnormalities in the prostate. It is quick and typically not painful.

Importance of DRE

DRE can detect prostate abnormalities that may not show up in a PSA test, providing an additional layer of screening.

Biopsy

When Biopsy is Recommended

If PSA levels are high or if there are abnormalities found during a DRE, a biopsy may be recommended to confirm the presence of cancer.

Process and Benefits

A biopsy involves taking small samples of prostate tissue to be examined under a microscope. It provides a definitive diagnosis and helps in planning treatment.

Dr Diagnostics: Your Trusted Partner

Overview of Dr Diagnostics

Dr Diagnostics in Basavanagudi, Bangalore, is renowned for its comprehensive health checkups and advanced diagnostic services, specializing in prostate cancer screening.

Advanced Technology and Facilities

The facility is equipped with state-of-the-art technology, including advanced PSA testing equipment, digital rectal exam tools, and biopsy capabilities.

Experienced Medical Professionals

The team at Dr Diagnostics includes experienced urologists, radiologists, and oncologists who provide expert care and personalized attention to each patient.

Screening Guidelines and Recommendations

Age Guidelines for Screening

Men aged 50 and above should consider regular prostate cancer screenings. Those with higher risk factors might need to start as early as 40.

Personal and Family History Considerations

Men with a family history of prostate cancer or other risk factors should discuss personalized screening schedules with their healthcare provider.

Frequency of Screenings

The frequency of screenings can vary based on individual risk factors. Generally, men should have annual screenings, but those at higher risk might need more frequent checks.

Innovations in Prostate Cancer Screening

Latest Research and Developments

Dr Diagnostics stays at the forefront of prostate cancer research, integrating the latest findings into their screening processes.

Technological Advances at Dr Diagnostics

The center continually updates its technology to provide the most accurate and efficient screening services available.

Future Directions in Prostate Cancer Screening

With ongoing research and technological advancements, the future of prostate cancer screening looks promising, with the potential for even earlier and more accurate detection.

Conclusion

Regular prostate cancer screening is vital for early detection and improved survival rates. Dr Diagnostics in Basavanagudi, Bangalore, offers state-of-the-art technology and expert care, making them the best choice for your screening needs. Don’t wait — schedule your screening today and take a proactive step towards your health.

[indiamedicaltourism]

Prostate Cancer Treatment in India for Foreign Patients

Prostate cancer is one of the most common cancers in men. It develops in the prostate gland. It is a small walnut-shaped gland that produces seminal fluid. The prostate is placed under the bladder. It is a blank hollow organ that manages to store urine. It is positioned in front of the rectum which is the end of the intestines. Prostate cancer begins when uncontrollable cells grow in the prostate gland that makes a lump or a tumor.

Prostate Cancer Treatment in India 

Prostate cancer is a very serious disease. It is treatable in the early stages before cancer spreads to the prostate gland. Some of the symptoms of prostate cancer as like; Trouble urinating, the urge to urinate frequently at night, blood in the semen, Pain or burning during urination, reduced force in the stream of urine, pain when sitting caused by an enlarged prostate, losing weight without trying, blood in the urine, etc. There are many types of Prostate cancer. Types are the following;

Adenocarcinoma. It is the most common type of prostate cancer. 

Small Cell Carcinomas

Transitional Cell Carcinomas

Neuroendocrine Tumors

Sarcomas. These are some rare types of prostate cancer.

Prostate cancer treatment depends on the stage of cancer in the prostate gland. The size of the tumor, patient condition & different therapies are given as required. Some of the prostate cancer treatment options are as particle therapy, radiation therapy, laparoscopic radical prostatectomy, radiosurgery, radical retropubic prostatectomy, chemotherapy, hormone & urinary retention medications, etc.

Prostate Cancer Treatment Cost in India

Prostate cancer treatment cost in India is based on various factors such as techniques, doctor’s expertise, equipment, patient medical conditions, city, and hospitals. This treatment starts from INR 1Lks up to 4.5Lks.

Best Prostate Cancer Treatment Hospitals in India 

India has many best quality hospitals for prostate cancer treatment that offer excellent cancer care. These hospitals are very well known for their best care, equipment, medical oncology, and other specialists. 

Fortis Memorial Research Institute (New Delhi)

Narayana Superspeciality Hospital (Gurgaon)

Indraprastha Apollo Hospitals (New Delhi)

Medanta- The Medicity (Gurgaon)

Kokilaben Dhirubhai Ambani Hospital (Mumbai)

Tata Memorial Hospital (Mumbai)

Top Prostate Cancer Treatment Doctors in India

There are many best oncology surgeons in India for treating against prostate cancer treatment. They have many years of knowledge, experience & expertise. Some of the doctor’s names are given below:  

Dr. Keshavamurthy Mohan (Uro-oncologist) 

Prof. Dr. Raj Nagarkar (Surgical oncologist)

Dr. Madhav Sanzgiri (Urology/Genito-urinary Surgery)

Dr. Kapil Kumar (Director& HOD of Surgical Oncology)

Dr. Lakshman Bellamkonda (Urologist, Andrologist & transplant surgeon)

 Dr. Vadhiraja B.M (HOD & Consultant Radiation Oncologist)

Al Afiya Medi Tour is a leading medical tourism company in India. We offer medical tourism services such as finding the right doctor, the right hospital, and cost estimation etc. Some of the main countries are Bangladesh, South Africa, Egypt, Uganda, Zambia, Sudan, Dubai, Namibia, Iraq, Kenya, Saudi Arabia, Ethiopia, Nigeria, and so on. We provide free medical assistance for TURP surgery cost, lung cancer treatment, cancer treatment cost, lung transplant, liver transplant cost, top knee replacement surgeons, knee replacement surgery cost, top shoulder replacement surgeons, etc.

Source: https://alafiyameditour1.blogspot.com/2024/05/prostate-cancer-treatment-in-india-for_9.html

[nursingscience]

There are more than 100 types of cancers. Here are some cancer names which are formed in specific cells.

▪️Carcinoma: Most common type of cancer. They are formed by epithelial cells, which are the cells that cover the inside and outside surfaces of the body. Example: Bladder, kidney, breast, prostate, colon, lungs, stomach, intestine, kidney cancers are associated.

▪️Sarcoma: Sarcomas are cancers that form in bone and soft tissues, including muscle, fat, blood vessels, lymph vessels, and fibrous tissue (such as tendons and ligaments).

▪️Leukemia: Cancers that begin in the blood-forming tissue of the bone marrow are called leukemias. These cancers do not form solid tumors. Instead, large numbers of abnormal white blood cells (leukemia cells and leukemic blast cells) build up in the blood and bone marrow, crowding out normal blood cells.

▪️Lymphoma: Lymphoma is cancer that begins in lymphocytes (T cells or B cells). These are disease-fighting white blood cells that are part of the immune system. In lymphoma, abnormal lymphocytes build up in lymph nodes and lymph vessels, as well as in other organs of the body.

▪️Multiple Myeloma: Multiple myeloma is cancer that begins in plasma cells, another type of immune cell. The abnormal plasma cells, called myeloma cells, build up in the bone marrow and form tumors in bones all through the body.

▪️Melanoma: Melanoma is cancer that begins in cells that become melanocytes, which are specialized cells that make melanin (the pigment that gives skin its color). Most melanomas form on the skin, but melanomas can also form in other pigmented tissues.

▪️Brain & Spinal Cord Tumors: There are different types of brain and spinal cord tumors. These tumors are named based on the type of cell in which they formed and where the tumor first formed in the central nervous system.

▪️Germ Cells Tumors: Germ cell tumors are a type of tumor that begins in the cells that give rise to sperm or eggs. These tumors can occur almost anywhere in the body.

▪️Neuroendocrine Tumors: Neuroendocrine tumors form from cells that release hormones into the blood in response to a signal from the nervous system. These tumors, which may make higher-than-normal amounts of hormones, can cause many different symptoms. Example, islet cell tumors, medullary thyroid cancer, pheochromocytomas, neuroendocrine carcinoma of the skin (Merkel cell cancer), small cell lung cancer etc.

▪️Carcinoid Tumors: Carcinoid tumors are a type of neuroendocrine tumor. They are slow-growing tumors that are usually found in the gastrointestinal system (most often in the rectum and small intestine). Carcinoid tumors may spread to the liver or other sites in the body, and they may secrete substances such as serotonin or prostaglandins, causing carcinoid syndrome.

Source: National Cancer Institute.

[novaglobalhealthcare]

Recent FDA-Approved Cancer Treatments and Therapies

Tisagenlecleucel (Kymriah) is the first personalized gene therapy in the United States for:

Children and adults with relapsed/refractory B-cell acute lymphoblastic leukemia (2017.)

Adults with relapsed and refractory aggressive B-cell lymphoma (2018.)

Adults with relapsed/refractory follicular lymphoma (2022.)

Tocilizumab (Actemra) treats side effects from cancer immunotherapy (2017.)

Olapirib (Lynparza) targets BRCA-mutated refractory ovarian cancer and metastatic breast cancer (2018) and early-stage breast cancer with BRCA1/2 mutations (2022.)

Iobenguane I 131 (Azedra) is the first and only treatment option for adults and children with advanced and inoperable pheochromocytomas and paragangliomas (2018.)

Gilteritinib (Xospata) is the first drug of its kind for relapsed or refractory FLT3-mutated acute myeloid leukemia (2018.)

Transoral Robotic Surgery (TORS) was approved as a technology for operating on head and neck cancers (2019.)

Selinexor (Xpovio) is the first treatment of its kind for relapsed/refractory multiple myeloma (2019.)

Entrectinib (Rozlytrek) targets NTRK-mutated cancers in children and adults and ROS1-mutated non-small-cell lung cancers in adults (2020.)

Fluoroestradiol F 18 (Cerianna) enables visual detection of recurrent breast cancer by PET scan (2020.)

Belantamab mafodotin-blmf (Blenrep) is the first antibody – drug conjugate that selectively targets and kills myeloma cells to treat relapsed/refractory multiple myeloma (2020.)

Crizotinib (Xalkori) treats relapsed/refractory ALK-mutated systemic anaplastic large-cell lymphoma as well as inflammatory ALK-mutated myofibroblastic tumors in children and young adults (2021-22.)

Belzutifan (Welirig) is the first therapy of its kind for treating von Hippel – Lindau disease-associated tumors, such as renal cell carcinoma, central nervous system hemangioblastomas and pancreatic neuroendocrine tumors (2021.)

Cabozantinib (Cabometyx) treats refractory differentiated thyroid cancer in children and adults (2021.)

Pafolacianine (Cytalux) is the first FDA-approved substance to illuminate ovarian cancer (2021) and lung cancer (2022) lesions during surgery.

Teclistamab-cqvy (Tecvayli) is the first bispecific T cell engager antibody for the treatment of patients with relapsed or refractory multiple myeloma (2022.)

Mosunetuzumab-axgb (Lunsumio) is a bispecific CD20-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy (2022.)

[riograndecancerspecialists]

Lung Cancer Diagnosis? Ask These Questions About Available Treatment Options

If you have just received a lung cancer diagnosis, you undoubtedly have a ton of questions at this point. It's normal to get a sense of overwhelm when discussing treatment options with your medical team.

Lung cancer can currently be treated in more ways than in the past. Combinations of techniques, such radiation therapy and chemotherapy, are frequently used in standard treatment. Promising new remedies are also available because of continuous research. Novel pharmacological treatments, such as targeted and immunotherapies, are frequently approved.

The best way to clear the underlying doubts is to ask questions to the doctor or the hospital. So, we have highlighted some of the most commonly asked questions related to lung cancer that you should put up.

What kind of lung cancer I have been suffering from?

The kind of lung cancer you have will dictate the kind of care you get. Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are the two primary forms of lung cancer. Adenocarcinoma, squamous cell carcinoma, and big cell carcinoma are the three main forms of non-small cell lung cancer.

What is the exact stage of my lung cancer?

The kind of treatment you receive will also depend on the stage of your cancer. Stages 0 (very early stage) to 4 (cancer has migrated beyond one lung and to another portion of the body) are the possible progressions of non-small cell lung cancer. The staging of small cell lung carcinoma varies. Physicians categorize the illness as either limited-stage or extensive-stage.

Has my tumor sample been sent for in-depth biomarker analysis?

Certain cancer subtypes can only be treated with specific cancer medications. Tumor testing, also known as biomarker testing, gives you precise information about the kind of lung cancer you have. Thus, biomarker testing could be used to assist you get the best possible treatment. It might also assist in determining your eligibility for particular clinical research.

What could the side effects of the ongoing treatment?

Ask how you can get ready for any anticipated adverse effects throughout your talk. You can enhance your quality of life and adhere to your El Paso cancer treatment plan by being prepared for frequent side effects prior to beginning therapy.

How quickly can lung cancer spread?

Compared to non-small cell lung cancer, small cell lung cancer often develops and spreads more quickly. At the time of diagnosis, around 70% of small cell lung tumors had already spread. Certain non-small cell lung cancers, like big cell neuroendocrine carcinoma and large cell undifferentiated carcinoma, are also expanding quickly.

Is there any risk of lung cancer surgery?

Depending on the features and degree of the malignancy, lung cancer surgery may require removing a small or big section of a lung, an entire lobe, or the entire lung. Therefore, a variety of factors, such as the operation type, surgical techniques employed, and other specific considerations, might impact the risks associated with surgery. Either way, getting rid of as much cancer as possible is the aim.

Can I do exercise while treating is ongoing?

Breathlessness may occasionally result from lung cancer, even while you are at rest. You may believe that exercising is impossible if you are having respiratory problems. However, this isn't always the case.

Even with your restricted lung capacity, you probably can and should engage in some physical activity on a daily basis. Strength, vitality, endurance, and quality of life are all things that exercise may help you with and are crucial to your overall health and recuperation.

What is the success rate of lung cancer treatment?

It is crucial to remember that general figures on lung cancer survival rates are derived from patient outcomes for whom the diagnosis occurred five to ten years ago. The prognoses for patients with all forms of lung cancer are steadily getting better because to recent medical advances like hormone therapy and immunotherapy. Furthermore, a patient's response to a particular treatment may be influenced by variables such as general health, diet, and heredity.

The Conclusion

Do you have more questions regarding your lung cancer treatment? If yes, consult a reputed El Paso cancer doctor at Rio Grande Cancer Specialist which serves El Paso, Las Cruces and the nearby communities.

Disclaimer The information provided in this content is just for educational purposes and is written by a professional writer. Consult us to know more about various available lung cancer treatment options. 

[ptmasterguide]

Everolimus (Clinical Studies-1)

In this article, we will discuss Everolimus (Clinical Studies-1). SO, let’s get started. Cancer Treatment: Everolimus has been investigated for its efficacy in various cancers, including breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumors, gastrointestinal stromal tumors, and more. Transplant Medicine: Everolimus has been studied for its use in preventing organ transplant…

[nuclearmedicinetherapy]

Which Patients can benefit with PRRT?

PRRT is a procedure that is used for treating Neuroendocrine Tumours (NETs) – gastro-entero-pancreatic NETs, which arise from the stomach, gastrointestinal tract, pancreas, islet cell carcinomas of the pancreas (These NETs are included in the US Federal Drug Administration {FDA} approved indication)

Know more at:

[dpathucgconforences]

New Speaker Announcement:  

We are happy to introduce our speaker Dr. Alison Finall at the CME/CPD accredited 11th World Digital Pathology & AI UCGCongress from December 15-17, 2023, in Holiday Inn Dubai, Al Barsha, UAE & Virtual.

Speech Title: Use of a rapid automated PCR assay to rescue failed RNA next generation sequencing for detection of gene fusion events in non-squamous, non-small cell neuroendocrine carcinoma (NSCLC) of the lung: a clinical, retrospective verification study

Hurry up Register Now: https://digitalpathology.ucgconferences.com/registration/ To Register Virtually visit: https://digitalpathology.ucgconferences.com/online-registration/ WhatsApp us: https://wa.me/442033222718?text=

[vanshika393]

High Grade Neuroendocrine Neoplasms Market - Size, Trends & Competition Analysis 2030 | Credence Research

                                    High Grade Neuroendocrine Neoplasms Market

The latest market report published by Credence Research, Inc. “Global High Grade Neuroendocrine Neoplasms Market: Growth, Future Prospects, and Competitive Analysis, 2023 – 2030. The global High Grade Neuroendocrine Neoplasms Market has been steadily growing in recent years and is predicted to grow at a 8.50% CAGR between 2023 and 2030. The market is anticipated to be worth USD XX million by 2030, up from USD XX million in 2022.

The term "High Grade Neuroendocrine Neoplasms Market" refers to the market for medical treatments, therapies, and related products and services that are specifically focused on high-grade neuroendocrine neoplasms (NENs). High-grade neuroendocrine neoplasms (NENs) are a group of rare and aggressive cancers that originate in neuroendocrine cells. These cells are found throughout the body, particularly in organs like the pancreas, lungs, gastrointestinal tract, and other endocrine glands. Neuroendocrine cells release hormones into the bloodstream and play a role in regulating various bodily functions.

High-grade NENs are characterized by their rapid growth and tendency to metastasize (spread to other parts of the body). They are considered more aggressive and have a poorer prognosis compared to low-grade NENs. These tumors are often classified as neuroendocrine carcinomas and can be further categorized based on their tissue of origin, such as small cell or large cell neuroendocrine carcinoma.

Diagnosis typically involves a combination of imaging tests (such as CT scans, MRI, or PET scans) and biopsies to confirm the presence of high-grade NENs. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, and targeted therapies. The specific treatment plan depends on factors like the tumor's location, stage, and whether it has spread to other parts of the body.

Because high-grade neuroendocrine neoplasms are aggressive, early diagnosis and prompt treatment are essential for improving outcomes and extending survival. Patients with these tumors often require close monitoring and ongoing medical care. The prognosis for high-grade NENs can vary widely depending on the individual case and the success of treatment. It is important for patients to work closely with a medical team specializing in neuroendocrine cancers to develop an appropriate treatment plan and receive the necessary support.

The high-grade neuroendocrine neoplasms (NENs) market, like any other medical field, faces several major challenges and risks. These challenges can impact patient care, research, and the development of new therapies. Here are some of the key challenges and risks associated with the high-grade NENs market:

Limited Understanding: High-grade NENs are relatively rare and complex tumors, which makes them less understood compared to more common cancers. Limited knowledge about the disease's biology, progression, and treatment options hampers effective management.

Late Diagnosis: High-grade NENs are often diagnosed at an advanced stage, leading to poorer outcomes. Lack of specific symptoms and low awareness among healthcare providers can contribute to delayed diagnosis.

Treatment Options: The treatment landscape for high-grade NENs is limited compared to other cancers. Standardized treatment protocols are lacking, and therapeutic options may include surgery, chemotherapy, targeted therapies, and peptide receptor radionuclide therapy (PRRT). Determining the most appropriate treatment can be challenging.

Tumor Heterogeneity: High-grade NENs are characterized by tumor heterogeneity, meaning that different parts of the tumor may have different characteristics and respond differently to treatment. This complicates treatment decisions and may lead to treatment resistance.

Some of the major players in the market and their market share are as follows:

Brain Storm Cell Therapeutics

Holostem Terapie Avanzate S.R.L

Pharmicell Co. Inc

Opexa Therapeutics

Caladrius Biosciences Inc

U.S. Stem Cell Inc

Lonza

Bristol Myers Squibb

Novartis

Autolus therapeutics

Browse 247 pages report High Grade Neuroendocrine Neoplasms Market By Primary Site of Origin (Pulmonary Neuroendocrine Neoplasms (Lung), Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs), Other Primary Sites (e.g., Neuroendocrine Neoplasms of the Thymus), By Tumor Grade and Stage (Grade 3 Neuroendocrine Neoplasms (Well-Differentiated), Small Cell Neuroendocrine Carcinomas (Poorly Differentiated) – Size, Share, Growth, Trends and Segment Forecasts to 2023-2030- https://www.credenceresearch.com/report/high-grade-neuroendocrine-neoplasms-market

High Grade Neuroendocrine Neoplasms Market Growth Factor Worldwide

The High Grade Neuroendocrine Neoplasms Market is experiencing significant growth worldwide, driven by several key factors. With an increasing prevalence of neuroendocrine tumors and a growing awareness among healthcare professionals regarding the diagnosis and treatment options for these rare malignancies, the market is poised to expand in the coming years. Furthermore, advancements in medical research have led to a better understanding of high-grade neuroendocrine neoplasms and the development of targeted therapies that can effectively combat these aggressive tumor types.

Additionally, favorable reimbursement policies for novel therapeutics and the availability of government funding for cancer research are further fueling market growth. Moreover, technological innovations in diagnostic imaging techniques such as positron emission tomography (PET) scans and molecular testing methods enable more accurate detection and staging of high-grade neuroendocrine neoplasms, facilitating timely intervention. The emergence of personalized medicine approaches tailored specifically to individual patients based on their genomic profile holds immense promise for improving overall survival rates in this patient population.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global High Grade Neuroendocrine Neoplasms Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global High Grade Neuroendocrine Neoplasms Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Complete Report- https://www.credenceresearch.com/report/high-grade-neuroendocrine-neoplasms-market

Visit our Website- https://www.credenceresearch.com

Related Reports- https://www.credenceresearch.com/report/bone-grafts-and-substitutes-market

https://www.credenceresearch.com/report/autologous-cell-therapy-market

Browse Our Blog- https://www.linkedin.com/pulse/high-grade-neuroendocrine-neoplasms-market-key-players-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India